{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:14:55Z","timestamp":1793146495582,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.compbiomed.2025.111366","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T13:34:34Z","timestamp":1764941674000},"page":"111366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Metabolic signatures of immune checkpoint inhibitor response in gynecologic cancers: Insights from flux balance analysis"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2784-038X","authenticated-orcid":false,"given":"Gideon","family":"Idumah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1578-9182","authenticated-orcid":false,"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6389-3059","authenticated-orcid":false,"given":"Lamis","family":"Yehia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0338-5239","authenticated-orcid":false,"given":"Ying","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2025.111366_bib1","article-title":"High TGF-\u03b2 signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition","volume":"5","author":"Ni","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111366_bib2","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdz135","article-title":"Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study","volume":"30","author":"Matulonis","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111366_bib3","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.18.01265","article-title":"Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase II KEYNOTE-158 study","volume":"37","author":"Chung","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111366_bib4","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1200\/JCO.2017.72.5952","article-title":"Safety and antitumor activity of pembrolizumab in advanced programmed death ligand 1-Positive endometrial cancer: results from the KEYNOTE-028 study","volume":"35","author":"Ott","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111366_bib5","first-page":"1","article-title":"Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies","volume":"11","author":"Phan","year":"2014","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.compbiomed.2025.111366_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.chembiol.2024.02.001","article-title":"Metabolic rewiring and communication in cancer immunity","volume":"31","author":"Chapman","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.compbiomed.2025.111366_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217076","article-title":"Metabolic reprogramming in tumor immune microenvironment: impact on immune cell function and therapeutic implications","volume":"597","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.compbiomed.2025.111366_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00018-020-03581-0","article-title":"Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resistance","volume":"78","author":"Wei","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.compbiomed.2025.111366_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006733","article-title":"Integration of single-cell RNA-seq data into population models to characterize cancer metabolism","volume":"15","author":"Damiani","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.compbiomed.2025.111366_bib10","first-page":"138","article-title":"Linking alterations in metabolic fluxes with shifts in metabolite levels by means of kinetic modeling","volume":"708","author":"Damiani","year":"2017","journal-title":"Comm. Com. Inf. Sc."},{"key":"10.1016\/j.compbiomed.2025.111366_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ymben.2016.10.022","article-title":"Genome scale metabolic modeling of cancer","volume":"43","author":"Nilsson","year":"2017","journal-title":"Metab. Eng."},{"key":"10.1016\/j.compbiomed.2025.111366_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41698-023-00418-4","article-title":"Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition","volume":"7","author":"Al-Sudani","year":"2023","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111366_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.compbiomed.2025.111366_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-018-2435-4","article-title":"Single sample scoring of molecular phenotypes","volume":"19","author":"Foroutan","year":"2018","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.compbiomed.2025.111366_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nprot.2009.203","article-title":"A protocol for generating a high-quality genome-scale metabolic reconstruction","volume":"5","author":"Thiele","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.compbiomed.2025.111366_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41596-019-0254-3","article-title":"A workflow for generating multi-strain genome-scale metabolic models of prokaryotes","volume":"15","author":"Norsigian","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.compbiomed.2025.111366_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nbt.4072","article-title":"Recon3D enables a three-dimensional view of gene variation in human metabolism","volume":"36","author":"Brunk","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.compbiomed.2025.111366_bib18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1089\/ars.2017.7048","article-title":"Genome-scale modeling of NADPH-driven beta-Lapachone sensitization in head and neck squamous cell carcinoma","volume":"29","author":"Lewis","year":"2018","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.compbiomed.2025.111366_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1752-0509-6-27","article-title":"Metabolic network analysis predicts efficacy of FDA-approved drugs targeting the causative agent of a neglected tropical disease","volume":"6","author":"Chavali","year":"2012","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.compbiomed.2025.111366_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/msb.2011.35","article-title":"Predicting selective drug targets in cancer through metabolic networks","volume":"7","author":"Folger","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.compbiomed.2025.111366_bib21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cels.2020.12.001","article-title":"Personalized genome-scale metabolic models identify targets of redox metabolism in radiation-resistant tumors","volume":"12","author":"Lewis","year":"2021","journal-title":"Cell Syst."},{"key":"10.1016\/j.compbiomed.2025.111366_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nbt.2488","article-title":"A community-driven global reconstruction of human metabolism","volume":"31","author":"Thiele","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.compbiomed.2025.111366_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1752-0509-6-153","article-title":"Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE","volume":"6","author":"Wang","year":"2012","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.compbiomed.2025.111366_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03641","article-title":"Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer","volume":"3","author":"Yizhak","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.compbiomed.2025.111366_bib25","doi-asserted-by":"crossref","first-page":"744","DOI":"10.15252\/msb.20145746","article-title":"A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration","volume":"10","author":"Yizhak","year":"2014","journal-title":"Mol. Syst. Biol."},{"issue":"157","key":"10.1016\/j.compbiomed.2025.111366_bib26","first-page":"53","article-title":"V12. 1: user's manual for CPLEX","volume":"46","author":"Cplex","year":"2009","journal-title":"Int. Business Mach. Corporat."},{"key":"10.1016\/j.compbiomed.2025.111366_bib27","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/BF02810081","article-title":"Relationship between in vitro growth promotion and biophysical and biochemical properties of the serum supplement","volume":"18","author":"Price","year":"1982","journal-title":"In Vitro"},{"key":"10.1016\/j.compbiomed.2025.111366_bib28","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/s41467-021-22173-5","article-title":"The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation","volume":"12","author":"Shang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2025.111366_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1326509","article-title":"Overexpression of MTHFD2 represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer","volume":"14","author":"Shi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiomed.2025.111366_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10863-024-10014-1","article-title":"Interference with MTHFD2 induces ferroptosis in ovarian cancer cells through ERK signaling to suppress tumor malignant progression","volume":"56","author":"Mo","year":"2024","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.compbiomed.2025.111366_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107864","article-title":"In cancer, all roads lead to NADPH","volume":"226","author":"Rather","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.compbiomed.2025.111366_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0891-5849(00)00331-2","article-title":"Enhanced oxidative stress and accelerated cellular senescence in glucose-6-phosphate dehydrogenase (G6PD)-deficient human fibroblasts","volume":"29","author":"Ho","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.compbiomed.2025.111366_bib33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/iub.1017","article-title":"Glucose-6-phosphate dehydrogenase, NADPH, and cell survival","volume":"64","author":"Stanton","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.compbiomed.2025.111366_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008441","article-title":"Blockade of glucose-6-phosphate dehydrogenase induces immunogenic cell death and accelerates immunotherapy","volume":"12","author":"Nakamura","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.compbiomed.2025.111366_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2025.07.017","article-title":"Succinate preserves CD8(+) T cell fitness to augment antitumor immunity","author":"Ma","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.compbiomed.2025.111366_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.compbiomed.2025.111366_bib37","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41568-018-0054-z","article-title":"Rewiring urea cycle metabolism in cancer to support anabolism","volume":"18","author":"Keshet","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.compbiomed.2025.111366_bib38","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.cell.2018.07.019","article-title":"Urea cycle dysregulation generates clinically relevant genomic and biochemical signatures","volume":"174","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.compbiomed.2025.111366_bib39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12964-025-02328-3","article-title":"Urea cycle dysregulation: a new frontier in cancer metabolism and immune evasion","volume":"23","author":"Shou","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.compbiomed.2025.111366_bib40","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1111\/febs.13295","article-title":"Oncometabolites: tailoring our genes","volume":"282","author":"Nowicki","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.compbiomed.2025.111366_bib41","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-020-2363-0","article-title":"Oncometabolites suppress DNA repair by disrupting local chromatin signalling","volume":"582","author":"Sulkowski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2025.111366_bib42","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1101\/gad.191056.112","article-title":"Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors","volume":"26","author":"Xiao","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.compbiomed.2025.111366_bib43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41581-019-0210-z","article-title":"Oncometabolites in renal cancer","volume":"16","author":"Yong","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.compbiomed.2025.111366_bib44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ajhg.2008.07.011","article-title":"Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes","volume":"83","author":"Ni","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.compbiomed.2025.111366_bib45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ajhg.2019.09.004","article-title":"Distinct alterations in tricarboxylic acid cycle metabolites associate with cancer and autism phenotypes in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome","volume":"105","author":"Yehia","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.compbiomed.2025.111366_bib46","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fmolb.2020.00150","article-title":"Association between succinate receptor SUCNR1 expression and immune infiltrates in ovarian cancer","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.compbiomed.2025.111366_bib47","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1529\/biophysj.106.093138","article-title":"Thermodynamics-based metabolic flux analysis","volume":"92","author":"Henry","year":"2007","journal-title":"Biophys. J."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525017202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525017202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:57:53Z","timestamp":1773874673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525017202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":47,"alternative-id":["S0010482525017202"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111366","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic signatures of immune checkpoint inhibitor response in gynecologic cancers: Insights from flux balance analysis","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111366"}}